Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding (TEAM-VTE)
Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding in Female Patients With VTE
Sponsor: Leiden University Medical Center
Terminated
Low enrolment
Other terminated trials from Leiden University Medical Center
Other Venous Thromboembolism trials with similar outcome
Listed as NCT04748393, this observational or N/A phase trial focuses on Venous Thromboembolism and remains terminated or withdrawn. Sponsored by Leiden University Medical Center, it has been updated 4 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Mar 2021 — Jul 2024 [monthly]
Terminated
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Leiden University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .